Close

Teva Pharma (TEVA), Eagle Pharma (EGRX) Announce FDA Acceptance of Liquid Bendamustine Hydrochloride NDa

April 14, 2015 8:21 AM EDT Send to a Friend
Teva Pharma (NYSE: TEVA) and Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announced that the New Drug Application (NDA) for a liquid ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login